Vical to Present at the Leerink Global Healthcare Conference
February 09, 2015 20:30 ET
|
Vical Incorporated
SAN DIEGO, Feb. 9, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will participate in a fireside chat discussion at the Leerink Global Healthcare Conference...
Vical and AnGes Announce Collaboration to Develop Therapy for Ebola Virus Disease
January 14, 2015 05:00 ET
|
Vical Incorporated
SAN DIEGO and TOKYO, Jan. 14, 2015 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) and AnGes MG (Tokyo:4563) announced today that they have entered into collaboration to develop and commercialize...
Vical Completes Enrollment in Its Therapeutic HSV-2 Vaccine Clinical Trial
December 11, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Dec. 11, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced the completion of enrollment in a Phase 1/2 trial of its Vaxfectin®-formulated therapeutic vaccine...
Vical to Present at the Piper Jaffray 26th Annual Healthcare Conference
November 25, 2014 21:00 ET
|
Vical Incorporated
SAN DIEGO, Nov. 25, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical to Present at the Stifel 2014 Healthcare Conference
November 11, 2014 21:00 ET
|
Vical Incorporated
SAN DIEGO, Nov. 11, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports Third Quarter 2014 Financial Results and Progress in Key Development Programs
October 30, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 30, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months and nine months ended September 30, 2014. The net loss for the third...
Vical Announces News Release and Conference Call Schedule for Third Quarter 2014 Financial Results
October 23, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 23, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three and nine months ended September 30, 2014,...
Vical Granted Six U.S. Patents for HSV-2 Vaccines
October 08, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 8, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today the issuance of six U.S. patents that provide broad coverage of DNA vaccines for herpes simplex virus type...
Vical to Present at the Rodman and Renshaw 16th Annual Global Investment Conference
September 04, 2014 06:30 ET
|
Vical Incorporated
SAN DIEGO, Sept. 4, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports Second Quarter 2014 Financial Results and Progress in Key Development Programs
July 31, 2014 06:00 ET
|
Vical Incorporated
SAN DIEGO, July 31, 2014 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three months and six months ended June 30, 2014. The net loss for the second...